Gilead Sciences
Price & Volume
Stats
See more52W Range | $114.30-$175.65 |
Market Cap | $211.2B |
Shares Short | 20M |
Financials
See moreRevenue (12 Mos) | $30.9B |
Revenue Growth (YoY) | 6.8% |
Gross Profit (12 Mos) | $24.7B |
Diluted EPS | -$3.13 |
News
See moreYahoo Finance • 2 days ago
Gilead (GILD) Stock Fair Value Edges Higher After Analyst Target Increases
Yahoo Finance • 2 days ago
What Avantis U.S. Equity ETF (AVUS) Bought: Exxon Mobil Leads on Oct. 29
Yahoo Finance • 5 days ago
Gilead's HIV Franchise Supports Growth Outlook, RBC Says
Yahoo Finance • 5 days ago
Gilead outlines ~$1.5B 2028 biktarvy revenue impact as 2026 base business guidance rises to $30.7B-$31.0B
About
CEO | Mr. Daniel Patrick O'Day |
CFO | Mr. Andrew D. Dickinson |
Address | 333 Lakeside Drive, Foster City, CA, United States, 94404 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 17,000 |